Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
Clinical trial NCT03937869 · COMPLETED
Trial details
- NCT number
- NCT03937869
- Sponsor
- Lupin Research Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2020-11-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.